国际麻醉学与复苏杂志
國際痳醉學與複囌雜誌
국제마취학여복소잡지
INTERNATIONAL JOURNAL OF ANESTHESIOLOGY AND RESUSCITATION
2011年
1期
56-59
,共4页
Intravenous anesthetic%γ-aminobutyric acid subtype A receptor%Tonic inhibition
背景 静脉麻醉药物通过对中枢神经递质及受体功能的影响,从而产生多种药理学效应,其中对γ-氨基丁酸A受体(γ-aminobutyric acid subtype A receptor,GABAA)功能的调节是目前全麻药理学效应机制研究的热点.目的 阐述GABAA受体可能是静脉麻醉药物产生多种临床药理学效应的潜在分子靶点.内容 静脉麻醉药作用于GABAA受体可以产生镇静、催眠、遗忘和抑制体动等绝大多数临床作用,由不同亚单位组成的不同GABAA受体亚型对同一种静脉麻醉药分别产生不同的药理学效应.趋向 深入探讨静脉麻醉药对GABAA受体亚型的影响,为合理解释全麻机制,指导临床应用和开发新一代静脉麻醉药具有借鉴作用.
揹景 靜脈痳醉藥物通過對中樞神經遞質及受體功能的影響,從而產生多種藥理學效應,其中對γ-氨基丁痠A受體(γ-aminobutyric acid subtype A receptor,GABAA)功能的調節是目前全痳藥理學效應機製研究的熱點.目的 闡述GABAA受體可能是靜脈痳醉藥物產生多種臨床藥理學效應的潛在分子靶點.內容 靜脈痳醉藥作用于GABAA受體可以產生鎮靜、催眠、遺忘和抑製體動等絕大多數臨床作用,由不同亞單位組成的不同GABAA受體亞型對同一種靜脈痳醉藥分彆產生不同的藥理學效應.趨嚮 深入探討靜脈痳醉藥對GABAA受體亞型的影響,為閤理解釋全痳機製,指導臨床應用和開髮新一代靜脈痳醉藥具有藉鑒作用.
배경 정맥마취약물통과대중추신경체질급수체공능적영향,종이산생다충약이학효응,기중대γ-안기정산A수체(γ-aminobutyric acid subtype A receptor,GABAA)공능적조절시목전전마약이학효응궤제연구적열점.목적 천술GABAA수체가능시정맥마취약물산생다충림상약이학효응적잠재분자파점.내용 정맥마취약작용우GABAA수체가이산생진정、최면、유망화억제체동등절대다수림상작용,유불동아단위조성적불동GABAA수체아형대동일충정맥마취약분별산생불동적약이학효응.추향 심입탐토정맥마취약대GABAA수체아형적영향,위합리해석전마궤제,지도림상응용화개발신일대정맥마취약구유차감작용.
Background General anesthetics produce a series of behavioral responses and widespread neurodepression,such as amnesia,sedation,and hypnosis. A promising candidate receptor for many of the clinically relevant actions of intravenous anesthetics is the γ-aminobutyric acid (GABA) subtype A receptor. Objective To review the GABAA receptor subtypes may underling the intravenous anesthetics,we summarize recent discoveries related to the effects of intravenous anesthetics on GABAAreceptors.Content Considerable progress has been made in dissecting the behavioral effects of general anesthetics according to the subunit composition of GABAA receptors. Including the identification of extrasynaptic GABAA receptors as sensitive targets for low concentrations of general anesthetics,this review focuses on GABAA receptors which are key targets that mediate most of the clinically predominant effects of intravenous anesthetics.Trend These findings offer an experimental basis for contemplating the ideal that receptor-regulators might someday form a part of our clinical armamentarium.